Home/Filings/4/0001213900-22-008933
4//SEC Filing

David Matthew T 4

Accession 0001213900-22-008933

CIK 0001410098other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:09 PM ET

Size

12.8 KB

Accession

0001213900-22-008933

Insider Transaction Report

Form 4
Period: 2022-02-18
David Matthew T
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2022-02-18100,000 total
    Exercise: $4.03Exp: 2032-02-18Common Stock (100,000 underlying)
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.32Exp: 2031-01-11Common Stock (80,000 underlying)
    80,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $5.63Exp: 2030-05-11Common Stock (125,000 underlying)
    125,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $4.08Exp: 2030-05-11Common Stock (125,000 underlying)
    125,000
  • Common Stock

    3,150
  • Stock Option (Right to Buy Common Stock)

    Exercise: $5.56Exp: 2031-11-01Common Stock (125,000 underlying)
    125,000
Footnotes (4)
  • [F1]These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
  • [F2]These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
  • [F3]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
  • [F4]These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001811612

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:09 PM ET
Size
12.8 KB